These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30117390)

  • 21. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.
    Andersson T; Flockhart DA; Goldstein DB; Huang SM; Kroetz DL; Milos PM; Ratain MJ; Thummel K
    Clin Pharmacol Ther; 2005 Dec; 78(6):559-81. PubMed ID: 16338273
    [No Abstract]   [Full Text] [Related]  

  • 22. Genotyping for drug-metabolizing enzymes--does the promise meet the reality?
    Gardiner SJ; Begg EJ
    Pharmacogenomics; 2004 Dec; 5(8):1033-6. PubMed ID: 15584874
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacogenetics approach to therapeutics.
    Koo SH; Lee EJ
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):525-32. PubMed ID: 16700889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
    Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
    Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of drug metabolizing enzymes in the effect and side-effect of the drugs].
    Vereczkey L; Jemnitz K; Monostory K; Veres Z; Kóbori L
    Orv Hetil; 2005 May; 146(19):947-52. PubMed ID: 15969306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research progress in epigenetic regulation of cytochrome P450 genes encoding drug metabolizing enzymes].
    Zhang L; Zhang GL
    Sheng Li Ke Xue Jin Zhan; 2010 Jun; 41(3):209-13. PubMed ID: 21416983
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of inducers on drug-metabolizing enzyme activity and on formation of reactive drug metabolites in the liver.
    Orrenius S; Thor H; Jernström B
    Ciba Found Symp; 1980; 76():25-42. PubMed ID: 6109599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism.
    Isvoran A; Louet M; Vladoiu DL; Craciun D; Loriot MA; Villoutreix BO; Miteva MA
    Drug Discov Today; 2017 Feb; 22(2):366-376. PubMed ID: 27693711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.
    Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG
    Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic analysis of human drug-metabolizing enzymes: preclinical drug development and toxicology.
    Henderson CJ; Wolf CR
    Mol Interv; 2003 Sep; 3(6):331-43. PubMed ID: 14993465
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug metabolism by the cytochrome p-450 enzyme. Variability of polymorphisms and exogenous carriers].
    Kreutzkamp B
    Med Monatsschr Pharm; 2006 Feb; 29(2):48-50. PubMed ID: 16506587
    [No Abstract]   [Full Text] [Related]  

  • 33. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
    Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
    Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gerhard Zbinden Memorial Lecture. Genetic polymorphism of drug metabolizing enzymes. Implications for toxicity of drugs and other xenobiotics.
    Ingelman-Sundberg M
    Arch Toxicol Suppl; 1997; 19():3-13. PubMed ID: 9079190
    [No Abstract]   [Full Text] [Related]  

  • 35. Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes.
    Zientek MA; Youdim K
    Drug Metab Dispos; 2015 Jan; 43(1):163-81. PubMed ID: 25297949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
    Lee B; Ji HK; Lee T; Liu KH
    Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural modelling of the human drug-metabolizing cytochromes P450.
    Lewis DF; Ito Y; Goldfarb PS
    Curr Med Chem; 2006; 13(22):2645-52. PubMed ID: 17017916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of drug metabolizing enzymes in clearance.
    Di L
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):379-93. PubMed ID: 24392841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of immobilized enzymes in drug metabolism studies.
    Dulik DM; Fenselau C
    FASEB J; 1988 Apr; 2(7):2235-40. PubMed ID: 3127263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of drug metabolizing enzymes in human liver cell line Hep G2.
    Dawson JR; Adams DJ; Wolf CR
    FEBS Lett; 1985 Apr; 183(2):219-22. PubMed ID: 3921402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.